ArticleJournal of cellular and molecular medicine2022

A novel monoclonal antibody associated with glucoside kills gastric adenocarcinoma AGS cells based on glycosylation target.

Heng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.